KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy
📊
Treatment Reviews
See user reviews and ratings for KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy
🔬
Mega-Study
See real-world data analysis for KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy
📚
Meta-Analysis
See a meta-analysis of all available research
🔍
Clinical Trials
See clinical trials related to KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy